Allianz Se Astrazeneca PLC Transaction History
Allianz Se
- $4.23 Trillion
- Q2 2025
A detailed history of Allianz Se transactions in Astrazeneca PLC stock. As of the latest transaction made, Allianz Se holds 7,219 shares of AZN stock, worth $605,168. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,219
Previous 2,904
148.59%
Holding current value
$605,168
Previous $213 Million
136.34%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...